AI assistant
Sending…
Predictive Oncology Inc. — Director's Dealing 2021
Apr 2, 2021
35106_dirs_2021-04-02_de8c9978-764b-4f10-b0e5-aa310d6e1b5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2021-04-01
Reporting Person: ENGLE J MELVILLE (Director, CEO and Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-01 | Common Stock | A | 4959 | — | Acquired | 9029 | Direct |
More from Predictive Oncology Inc.
Capital/Financing Update
2026
Jun 9
Regulatory Filings
2026
Jun 9
Earnings Release
2026
May 15
Capital/Financing Update
2026
May 15
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 16
Board/Management Information
2026
Apr 1